Real-world data demonstrate the efficacy of the CVAC System across varied clinical settings, showing significant reductions in absolute stone volume and fewer complications compared to the flexible ...

-- Dana G. Mead, Jr. brings 30 years of expertise in product strategy, development and commercialization to the Calyxo boardroom, as the company marks its next stage of growth. -- More than 20,000 ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, announced that it has received FDA clearance for its new, ...

PLEASANTON, Calif., April 23, 2025--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, today announced that as part of its ongoing ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next-generation treatment solutions, announced this ...

The SURE Procedure with the CVAC System delivers 97% stone clearance independent of baseline stone volume; first and only prospective kidney stone clinical study to use continuous volumetric ...

THOMASVILLE- Archbold Urologist Eric Webb, MD, is the first in Georgia to perform a revolutionary kidney stone treatment using a new system known as the CVAC system. The CVAC system, approved by the ...

-- More than 20,000 patients have been treated with the CVAC System, underscoring the increasing adoption of the SURE procedure and its impact in kidney stone care. “Calyxo is at an exciting ...